Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Bausch Health Companies Inc before investing.

In this article, we go over a few key elements for understanding Bausch Health Companies Inc’s stock price such as:

• Bausch Health Companies Inc’s current stock price and volume
• Why Bausch Health Companies Inc’s stock price changed recently
• Upgrades and downgrades for BHC from analysts
• BHC’s stock price momentum as measured by its relative strength

About Bausch Health Companies Inc (BHC)

Before we jump into Bausch Health Companies Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

Want to learn more about Bausch Health Companies Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Bausch Health Companies Inc.

Bausch Health Companies Inc’s Stock Price as of Market Close

As of May 17, 2024, 3:59 PM, CST, Bausch Health Companies Inc’s stock price was $6.77.

Bausch Health Companies Inc is down 4.24% from its previous closing price of $7.07.

During the last market session, Bausch Health Companies Inc’s stock traded between $7.00 and $7.14. Currently, there are 366.80 million shares of Bausch Health Companies Inc stock available for purchase.

Unfortunately, Bausch Health Companies Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Bausch Health Companies Inc Stock Price History

Bausch Health Companies Inc’s (BHC) price is currently down 22.72% so far this month.

During the month of May, Bausch Health Companies Inc’s stock price has reached a high of $9.01 and a low of $6.72.

Over the last year, Bausch Health Companies Inc has hit prices as high as $11.46 and as low as $6.00. Year to date, Bausch Health Companies Inc’s stock is up 7.8%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Bausch Health Companies Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 16, 2024, there were 4 analysts who downgraded Bausch Health Companies Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Bausch Health Companies Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Bausch Health Companies Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Bausch Health Companies Inc’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Bausch Health Companies Inc (BHC) by visiting AAII Stock Evaluator.

Relative Price Strength of Bausch Health Companies Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 16, 2024, Bausch Health Companies Inc has a weighted four-quarter relative price strength of -9.16%, which translates to a Momentum Score of 33 and is considered to be Weak.

Want to learn more about how Bausch Health Companies Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Bausch Health Companies Inc Stock Price: Bottom Line

As of May 17, 2024, Bausch Health Companies Inc’s stock price is $6.77, which is down 4.24% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Bausch Health Companies Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.